ONCY

#6130
Oncolytics Biotech, Inc. Common Shares
1.13
+7.62%
부문:
베이스:
수익 통화:
일일 변동 비율
1.13
1.13
년간 변동
0.33
1.51
일일 변동
+7.62%
월간 변동
-1.74%
6달 변화
+6.60%
년간 변동율
+66.18%
이전 종가
1.05
Open
1.13
Bid
Ask
Low
1.13
High
1.13
양
13
Open full chart

Financials

Overview 성명 Statistics Dividends
Quarterly Annual
Value Q4, 24 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Oncolytics Biotech Inc

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

뉴스